Journey Medical Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DERM, updated each market day.
DERM AI Sentiment
AI sees no strong directional signal for Journey Medical Corporation Common Stock stock over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Journey Medical Corporation Common Stock
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Sector
Exchange
Market Cap
$207,731,547
Cap Tier
Employees
58
Headquarters
SCOTTSDALE, AZ
Listed Since
Nov. 12, 2021
Website
DERM Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DERM Volatility
Journey Medical Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
